The review emphasizes how breakthroughs in understanding the molecular mechanisms of cell cycle regulation have paved the way for the development of targeted anti-cancer agents. Notably, inhibitors of ...
Your doctor will check your blood at regular intervals during treatment. When you start taking these medications, your doctor may do blood tests once every two weeks. After the first couple of visits, ...
A precision cancer strategy that selectively kills tumour cells while leaving healthy tissue intact may be within reach for the majority of colorectal cancer patients, according to new research ...
Tarlatamab is a bispecific T-cell engager (BiTE) that binds to delta-like ligand-3 (DLL3) on small cell lung cancer (SCLC) cells and cluster of differentiation-3 on T cells, thereby delivering ...
Chimeric antigen receptor T-cell therapy—CAR T for short—has been a major advance in treating blood cancers like leukemia and ...
Researchers at MUSC Hollings Cancer Center have discovered a potentially powerful weapon in the fight against head and neck cancers. The new drug, still in preclinical studies, attacks cancer cells ...
Wahnefried, Ph.D. and Benjamin Larimer, Ph.D. Researchers at the University of Alabama at Birmingham are advancing cancer ...
Morning Overview on MSN
Metabolic enzyme may predict who benefits from cancer immunotherapy
A metabolic enzyme found in the support cells surrounding tumors may hold the key to predicting which cancer patients will ...
A recent study published in the International Journal of Molecular Sciences explores how deuterium concentration, an ...
Neoadjuvant chemoimmunotherapy demonstrated high pathological response rates with “manageable” toxicity in patients with squamous cell lung cancer, according to data presented at European Lung Cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results